These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28733955)

  • 1. Detection of Plasma Biomarkers Using Immunomagnetic Reduction: A Promising Method for the Early Diagnosis of Alzheimer's Disease.
    Yang SY; Chiu MJ; Chen TF; Horng HE
    Neurol Ther; 2017 Jul; 6(Suppl 1):37-56. PubMed ID: 28733955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an ultra-high sensitive immunoassay with plasma biomarker for differentiating Parkinson disease dementia from Parkinson disease using antibody functionalized magnetic nanoparticles.
    Yang SY; Chiu MJ; Lin CH; Horng HE; Yang CC; Chieh JJ; Chen HH; Liu BH
    J Nanobiotechnology; 2016 Jun; 14(1):41. PubMed ID: 27278241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analyzer-to-Analyzer Variations in Assaying Ultralow Concentrated Biomarkers Associated with Neurodegenerative Diseases Using Immunomagnetic Reduction.
    Lee KH; Hsu MH; Chen HH; Yang SY
    ACS Meas Sci Au; 2023 Dec; 3(6):488-495. PubMed ID: 38145030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight-Channel AC Magnetosusceptometer of Magnetic Nanoparticles for High-Throughput and Ultra-High-Sensitivity Immunoassay.
    Chieh JJ; Wei WC; Liao SH; Chen HH; Lee YF; Lin FC; Chiang MH; Chiu MJ; Horng HE; Yang SY
    Sensors (Basel); 2018 Mar; 18(4):. PubMed ID: 29601532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    Yang CC; Chiu MJ; Chen TF; Chang HL; Liu BH; Yang SY
    J Alzheimers Dis; 2018; 61(4):1323-1332. PubMed ID: 29376870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases.
    Yang SY; Chiu MJ; Chen TF; Lin CH; Jeng JS; Tang SC; Lee YF; Yang CC; Liu BH; Chen HH; Wu CC
    Sci Rep; 2017 Aug; 7(1):9304. PubMed ID: 28839167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of Immunomagnetic Reduction Technology as a Biosensor in Therapeutic Evaluation of Chinese Herbal Medicine in Tauopathy Alleviation of an AD
    Su MT; Lu CW; Wu WJ; Jheng YS; Yang SY; Chuang WC; Lee MC; Wu CH
    Biosensors (Basel); 2022 Oct; 12(10):. PubMed ID: 36291020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology.
    Lue LF; Kuo YM; Sabbagh M
    Neurol Ther; 2019 Dec; 8(Suppl 2):95-111. PubMed ID: 31833027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a 36-Channel Instrument for Assaying Biomarkers of Ultralow Concentrations Utilizing Immunomagnetic Reduction.
    Chen HH; Hsu MH; Lee KH; Yang SY
    ACS Meas Sci Au; 2022 Oct; 2(5):485-492. PubMed ID: 36785659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biofunctionalized magnetic nanoparticles for specifically detecting biomarkers of Alzheimer's disease in vitro.
    Yang CC; Yang SY; Chieh JJ; Horng HE; Hong CY; Yang HC; Chen KH; Shih BY; Chen TF; Chiu MJ
    ACS Chem Neurosci; 2011 Sep; 2(9):500-5. PubMed ID: 22860173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts.
    Lue LF; Sabbagh MN; Chiu MJ; Jing N; Snyder NL; Schmitz C; Guerra A; Belden CM; Chen TF; Yang CC; Yang SY; Walker DG; Chen K; Reiman EM
    Front Aging Neurosci; 2017; 9():226. PubMed ID: 28790911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic Reduction Detects Plasma Aβ
    Yang SY; Liu HC; Chen WP
    Neurol Ther; 2020 Dec; 9(2):435-442. PubMed ID: 33090326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-highly sensitive and wash-free bio-detection of H5N1 virus by immunomagnetic reduction assays.
    Yang SY; Chieh JJ; Wang WC; Yu CY; Lan CB; Chen JH; Horng HE; Hong CY; Yang HC; Huang W
    J Virol Methods; 2008 Nov; 153(2):250-2. PubMed ID: 18760307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Time to Detection on the Measured Concentrations of Blood Proteins Associated with Alzheimer's Disease.
    Chen HH; Ho CS; Hsu MH; Lin YC; Chang JF; Yang SY
    Dement Geriatr Cogn Dis Extra; 2022; 12(2):82-89. PubMed ID: 35702342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent.
    Kim H; Lee JU; Kim S; Song S; Sim SJ
    ACS Sens; 2019 Mar; 4(3):595-602. PubMed ID: 30747516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies.
    Bousiges O; Cretin B; Lavaux T; Philippi N; Jung B; Hezard S; Heitz C; Demuynck C; Gabel A; Martin-Hunyadi C; Blanc F
    J Alzheimers Dis; 2016; 51(4):1069-83. PubMed ID: 26923009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.
    Lue LF; Guerra A; Walker DG
    Neurol Ther; 2017 Jul; 6(Suppl 1):25-36. PubMed ID: 28733956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease.
    Tzen KY; Yang SY; Chen TF; Cheng TW; Horng HE; Wen HP; Huang YY; Shiue CY; Chiu MJ
    ACS Chem Neurosci; 2014 Sep; 5(9):830-6. PubMed ID: 25054847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.